Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 18848 [2015-07997]
Download as PDF
<![CDATA[
18848
Federal Register / Vol. 80, No. 67 / Wednesday, April 8, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Number of
responses per
respondent
Avg. burden
per response
(in hrs)
Total burden
(in hrs)
Type of respondents
Form name
Local Health Department Representative.
Older Adult—Screened Out ..............
Older Adult—Participant ...................
Interview Guide for Local Health Department Representative.
Senior Village Survey .......................
Senior Village Survey .......................
15
1
30/60
8
1,431
1,550
1
1
1/60
20/60
24
517
Total ...........................................
...........................................................
........................
........................
........................
580
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–08027 Filed 4–7–15; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
asabaliauskas on DSK5VPTVN1PROD with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
(FOA) DP15–001, Natural Experiments
of the Impact of Population-targeted
Health Policies to Prevent Diabetes and
its Complications.
Time And Date: 11 a.m.–6 p.m., May
5–6, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters For Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Natural Experiments of the Impact of
Population-targeted Health Policies to
Prevent Diabetes and its Complications,
DP15–001, initial review.’’
Contact Person For More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
Jkt 235001
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
[FR Doc. 2015–07997 Filed 4–7–15; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
17:55 Apr 07, 2015
[60Day–15–1005; Docket No. CDC–2015–
0018]
readiness to adopt mobility-protective
behaviors in older adults.
DATES: Written comments must be
received on or before June 8, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0018 by any of the following methods:
Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the information collection
request for reinstatement with change of
the collection previously approved
under OMB control number 0920–
1005—‘‘Conduct an Older Adult
Mobility Assessment Tool Impact
Evaluation and Develop a
Dissemination Plan’’. This collection
will help evaluate whether the Mobility
Planning Tool is effective for promoting
SUMMARY:
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\08APN1.SGM
08APN1
]]>Agencies
[Federal Register Volume 80, Number 67 (Wednesday, April 8, 2015)]
[Notices]
[Page 18848]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07997]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to (FOA) DP15-001, Natural Experiments of the
Impact of Population-targeted Health Policies to Prevent Diabetes and
its Complications.
Time And Date: 11 a.m.-6 p.m., May 5-6, 2015 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters For Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Natural Experiments of the Impact of Population-targeted Health
Policies to Prevent Diabetes and its Complications, DP15-001, initial
review.''
Contact Person For More Information: Brenda Colley Gilbert, Ph.D.,
M.S.P.H., Director, Extramural Research Program Operations and
Services, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia
30341, Telephone: (770) 488-6295, BJC4@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-07997 Filed 4-7-15; 8:45 am]
BILLING CODE 4163-18-P
